Echinacea pallida
Echinacea pallida · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Echinacea pallida is a notable botanical species frequently studied for its diverse therapeutic activities, including antibacterial, antiviral, and inotropic properties. The medicinal potency of this plant is primarily driven by key chemical constituents such as cichoric acid, chlorogenic acid, echinacoside, and caftaric acid. Research often focuses on the efficacy of various preparations, ranging from root-based components to 75% (v/v) ethanol extracts derived from the aerial parts. While these extracts show promise in addressing bacterial infections and cancer, careful consideration must be given to contraindications and their impact on CYP3A4 metabolism. Consequently, understanding the complex profile of this plant is essential for its application in modern pharmacology.
- Synonyms
- Rudbeckia Pallida · Echinacea Pallida F. Albida · 1 more
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Not available
- Plant Parts
- Root
Classification
Common Names
Echinacea pallida is a resilient perennial known by several different names depending on the region and language. In English-speaking areas, it is most frequently referred to as the pale purple coneflower. Its botanical identity carries diverse linguistic labels, such as Halvány kasvirág in Hungarian and Jeżówka blada in Polish. Moving across Central Europe, the plant is also recognized as Třapatkovka bledá in Czech and blek solhatt in Slovak. Regardless of these many common names, this striking flower remains a beloved staple in gardens worldwide.
Sources: Catalogue of Life (COL)
Synonyms
Echinacea pallida is a botanical subject frequently identified by several different scientific names in various taxonomic records. It is formally recognized by the synonym Brauneria pallida, a name that highlights its historical classification. Additionally, the plant is associated with the specific variety known as Echinacea pallida f. albida. Some older botanical texts may even list it under the synonym Rudbeckia pallida. Understanding these various nomenclatural relationships is essential for accurate identification and study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Echinacea pallida belongs to the vast kingdom Plantae, representing the diverse beauty of the natural world. Within this kingdom, the species is classified under the class Equisetopsida. It follows the biological order Asterales, which connects it to many other significant flowering plants. As a member of the genus Echinacea, it shares unique structural characteristics with its close relatives. Finally, this plant is a distinguished representative of the Asteraceae family, often recognized by its iconic composite flower heads.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Echinacea |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Echinacea pallida is a resilient species widely distributed across various regions of Northern America. Its presence extends into the eastern reaches of Canada, specifically throughout Ontario. Moving southward, the plant is commonly found throughout the North-Central United States. It thrives across several key states, including Illinois, Iowa, and Kansas. Additionally, this species maintains a notable distribution within the state of Missouri.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Echinacea pallida is a delicate herb characterized by its compact and self-supporting growth form. This resilient plant typically reaches a modest maximum height of only 0.37 meters. Its structured yet low-profile stature makes it a unique addition to any botanical collection.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Echinacea pallida is recognized for its significant therapeutic potential in modulating the body's immune response. Research indicates that this specific species possesses potent antibacterial activity, making it effective against various respiratory and skin pathogens. Furthermore, the plant exhibits notable antiviral properties that can help combat viruses such as influenza and rhinovirus. These biological effects are largely driven by key bioactive compounds like alkamides and polysaccharides that enhance immune cell activity. Consequently, Echinacea pallida serves as a promising complementary option alongside conventional treatments for managing infectious threats.
Compounds
Echinacea pallida is a medicinal herb recognized for its complex profile of bioactive phytochemical constituents. Research indicates that this specific species contains several important phenolic compounds, including chlorogenic acid and cichoric acid. Additionally, the plant serves as a source of echinacoside and caftaric acid, which are key to its chemical makeup. The presence of cynarin further contributes to the diverse array of compounds found within its roots and aerial parts. Understanding these specific relationships is essential for optimizing the harvest and production of high-quality medicinal preparations.
Conditions
Echinacea pallida is widely recognized for its use in treating the "common cold" and upper respiratory tract symptoms. The plant also demonstrates significant antioxidant capacity by treating the 1,1-diphenyl-2-picrylhydrazyl radical and the ABTS radical. Furthermore, this species possesses notable anti-inflammatory activity that helps modulate immune responses. Specifically, its alcohol extracts have been shown to increase the arginase activity of RAW 264.7 cells stimulated with 8-bromo-cAMP. These combined properties suggest that the plant works through multiple metabolites to promote alternative macrophage activation.
Preparations
Echinacea pallida is prepared as a 75% (v/v) ethanol extract from its aerial parts for use in safety assessments involving Sprague-Dawley rats. This species is also utilized in the form of alcohol extracts, which have been shown to inhibit nitric oxide production in macrophage cells. Research further identifies that ethanol extracts of the plant can stimulate glucuronidation and inhibit P-glycoprotein transporters in intestinal cells. More broadly, the plant is processed into various extracts for clinical and pharmacological study. Additionally, preparations of the species can be found as a homeopathic mother tincture, with active component concentrations varying significantly depending on the remedy type.
Parts used
Echinacea pallida is a widely utilized medicinal species known for its significant therapeutic potential. Research highlights that the root of this plant serves as a primary source for essential phytochemical constituents. Specifically, the roots contain important lipophilic compounds and phenolic acids, such as cichoric acid and echinacoside, which are linked to immunomodulating effects. Studies have shown that the concentration of these active components in the root fluctuates based on seasonal variations and the specific part of the plant used. Consequently, understanding the chemical profile of the Echinacea pallida root is vital for producers aiming to create effective medicinal preparations.